These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 16413239)

  • 1. Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.
    Leitner JM; Firbas C; Mayr FB; Reiter RA; Steinlechner B; Jilma B
    Clin Pharmacol Ther; 2006 Jan; 79(1):23-34. PubMed ID: 16413239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acenocoumarol decreases tissue factor-dependent coagulation during systemic inflammation in humans.
    Hollenstein U; Homoncik M; Knöbl P; Pernerstorfer T; Graggaber J; Eichler HG; Handler S; Jilma B
    Clin Pharmacol Ther; 2002 May; 71(5):368-74. PubMed ID: 12011822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin-induced coagulation.
    Leitner JM; Jilma B; Mayr FB; Cardona F; Spiel AO; Firbas C; Rathgen K; Stähle H; Schühly U; Graefe-Mody EU
    Clin Pharmacol Ther; 2007 Jun; 81(6):858-66. PubMed ID: 17410124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
    Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
    Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans.
    Jilma B; Marsik C; Mayr F; Graninger MT; Taylor FB; Ribel MC; Erhardtsen E; Handler S; Eichler HG
    Clin Pharmacol Ther; 2002 Oct; 72(4):403-10. PubMed ID: 12386642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia.
    Derhaschnig U; Pernerstorfer T; Knechtelsdorfer M; Hollenstein U; Panzer S; Jilma B
    Crit Care Med; 2003 Apr; 31(4):1108-12. PubMed ID: 12682480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia.
    Pajkrt D; Lerch PG; van der Poll T; Levi M; Illi M; Doran JE; Arnet B; van den Ende A; ten Cate JW; van Deventer SJ
    Thromb Haemost; 1997 Feb; 77(2):303-7. PubMed ID: 9157586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia.
    van der Poll T; Jansen PM; Montegut WJ; Braxton CC; Calvano SE; Stackpole SA; Smith SR; Swanson SW; Hack CE; Lowry SF; Moldawer LL
    J Immunol; 1997 Feb; 158(4):1971-5. PubMed ID: 9029140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia.
    Renckens R; Weijer S; de Vos AF; Pater JM; Meijers JC; Hack CE; Levi M; van der Poll T
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):483-8. PubMed ID: 14739127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the pan-selectin antagonist bimosiamose (TBC1269) in experimental human endotoxemia.
    Mayr FB; Firbas C; Leitner JM; Spiel AO; Reiter RA; Beyer D; Meyer M; Wolff G; Jilma B
    Shock; 2008 Apr; 29(4):475-82. PubMed ID: 18598003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor necrosis factor alpha -308 G/A polymorphism does not influence inflammation and coagulation response in human endotoxemia.
    Kovar FM; Marsik C; Cvitko T; Wagner OF; Jilma B; Endler G
    Shock; 2007 Mar; 27(3):238-41. PubMed ID: 17304103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of anticoagulation on thrombopoietin release during endotoxemia.
    Jilma-Stohlawetz P; Folman CC; von dem Borne AE; Pernerstorfer T; Hollenstein U; Knechtelsdorfer M; Eichler HG; Jilma B
    J Lab Clin Med; 2001 Jan; 137(1):64-9. PubMed ID: 11150025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lepirudin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen JB; Stohlawetz P; Eichler HG; Handler S; Speiser W; Jilma B
    Blood; 2000 Mar; 95(5):1729-34. PubMed ID: 10688831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin blunts endotoxin-induced coagulation activation.
    Pernerstorfer T; Hollenstein U; Hansen J; Knechtelsdorfer M; Stohlawetz P; Graninger W; Eichler HG; Speiser W; Jilma B
    Circulation; 1999 Dec 21-28; 100(25):2485-90. PubMed ID: 10604885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans.
    Verbon A; Meijers JC; Spek CA; Hack CE; Pribble JP; Turner T; Dekkers PE; Axtelle T; Levi M; van Deventer SJ; Reitsma PH; van der Poll T
    J Infect Dis; 2003 Jan; 187(1):55-61. PubMed ID: 12508146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo.
    Ekholm M; Kahan T; Jörneskog G; Bröijersen A; Wallén NH
    Thromb Res; 2009 May; 124(1):110-5. PubMed ID: 19195683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation.
    Choi G; Vlaar AP; Schouten M; Van't Veer C; van der Poll T; Levi M; Schultz MJ
    Eur Respir J; 2007 Sep; 30(3):423-8. PubMed ID: 17537762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia.
    Derhaschnig U; Reiter R; Knöbl P; Baumgartner M; Keen P; Jilma B
    Blood; 2003 Sep; 102(6):2093-8. PubMed ID: 12750166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dobutamine does not influence inflammatory pathways during human endotoxemia.
    Lemaire LC; de Kruif MD; Giebelen IA; Levi M; van der Poll T; Heesen M
    Crit Care Med; 2006 May; 34(5):1365-71. PubMed ID: 16540959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.